| Zachary Alan Webb, MD | |
|
1345 King St, Bellingham, WA 98229-6223 | |
| (360) 676-1696 | |
| (360) 676-6636 |
| Full Name | Zachary Alan Webb |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 26 Years |
| Location | 1345 King St, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063426146 | NPI | - | NPPES |
| 5111WE | Other | WA | REGENCE |
| 8429920 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD00045189 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstar Associates, Pllc | 0840196564 | 2 |
News Archive
The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis - blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease - may be a first step towards a new era in the treatment of such disorders.
Following significant advances in vaccine and microbicide research, including results presented today of 39% efficacy in the CAPRISA 004 microbicide gel trial among women in South Africa, a new report released today warns that flat funding for HIV prevention research may limit researchers' ability to quickly move promising approaches forward.
Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.
Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.
TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer drugs and deliver them faster to patients in need, the companies announced today.
› Verified 5 days ago
| Entity Name | Northstar Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912921586 PECOS PAC ID: 0840196564 Enrollment ID: O20050419000886 |
News Archive
The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis - blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease - may be a first step towards a new era in the treatment of such disorders.
Following significant advances in vaccine and microbicide research, including results presented today of 39% efficacy in the CAPRISA 004 microbicide gel trial among women in South Africa, a new report released today warns that flat funding for HIV prevention research may limit researchers' ability to quickly move promising approaches forward.
Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.
Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.
TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer drugs and deliver them faster to patients in need, the companies announced today.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zachary Alan Webb, MD 1345 King St, Bellingham, WA 98229-6223 Ph: (360) 676-1696 | Zachary Alan Webb, MD 1345 King St, Bellingham, WA 98229-6223 Ph: (360) 676-1696 |
News Archive
The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis - blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease - may be a first step towards a new era in the treatment of such disorders.
Following significant advances in vaccine and microbicide research, including results presented today of 39% efficacy in the CAPRISA 004 microbicide gel trial among women in South Africa, a new report released today warns that flat funding for HIV prevention research may limit researchers' ability to quickly move promising approaches forward.
Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.
Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.
TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer drugs and deliver them faster to patients in need, the companies announced today.
› Verified 5 days ago
Mr. Ronald A Remick, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 609 N Shore Dr, Bellingham, WA 98226 Phone: 360-676-6000 Fax: 360-676-6006 | |
Dr. Neelam Kumari Sampley, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1133 Railroad Ave Ste 100, Bellingham, WA 98225 Phone: 916-835-0144 | |
Ario H Hosseini, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1050 Larrabee Ave Ste 104-510, Bellingham, WA 98225 Phone: 360-200-8962 | |
Dr. Andrew Denzil Pauli, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1116 Key St Ste 200, Bellingham, WA 98225 Phone: 360-671-1369 Fax: 360-671-0981 | |
Danielle L Kizer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Attn:behavioral Health Services, Bellingham, WA 98225 Phone: 360-788-6993 Fax: 360-715-6996 | |
Dr. James M Harle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1112 11th Street, 301, Bellingham, WA 98225 Phone: 360-414-2222 Fax: 360-414-2220 |